Literature DB >> 7991123

Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds.

B M van Geel1, J Assies, G J Weverling, P G Barth.   

Abstract

X-linked adrenoleukodystrophy (X-ALD) is an inherited disorder of peroxisomal beta-oxidation associated with accumulation of saturated very long-chain fatty acids, which results in central and peripheral demyelination and in impaired function of adrenal cortex and testes. The phenotypic expression is highly variable, childhood cerebral ALD (CCALD) and adrenomyeloneuropathy (AMN) being the main variants. We explored the 30 Dutch kindreds well known to the Dutch X-ALD/AMN Study Group and phenotyped 77 male patients: 35 (46%) had AMN and 24 (31%) CCALD or adolescent cerebral ALD (AdolCALD). These percentages differ significantly from previous reports, in which 25 to 28% of the patients developed AMN and 53 to 57% CCALD or AdolCALD. Our findings indicate that--at least in the Netherlands--AMN may be the most frequent phenotype of X-ALD.

Entities:  

Mesh:

Year:  1994        PMID: 7991123     DOI: 10.1212/wnl.44.12.2343

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".

Authors:  B M van Geel; J Assies; E B Haverkort; J H Koelman; B Verbeeten; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  X-linked adrenoleukodystrophy: first report of the Italian Study Group.

Authors:  A Di Biase; S Salvati; C Avellino; M Cappa; E Bertini; I Moroni; M Rimoldi; G Uziel
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 3.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 4.  On the front of X-linked adrenoleukodystrophy.

Authors:  P Aubourg
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

5.  Asymptomatic adrenoleukodystrophy in elderly males.

Authors:  Chiara Benzoni; Silvia Fenu; Viviana Pensato; Elena Mauro; Cinzia Gellera; Davide Pareyson; Ettore Salsano
Journal:  J Neurol       Date:  2020-04-20       Impact factor: 4.849

Review 6.  DNA diagnosis of X-linked adrenoleukodystrophy.

Authors:  S Seneca; W Lissens
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Identification of a new fatty acid synthesis-transport machinery at the peroxisomal membrane.

Authors:  Merle Hillebrand; Søren W Gersting; Amelie S Lotz-Havla; Annika Schäfer; Hendrik Rosewich; Oliver Valerius; Ania C Muntau; Jutta Gärtner
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

Review 8.  Adrenomyeloneuropathy as a cause of primary adrenal insufficiency and spastic paraparesis.

Authors:  Monika Spurek; Regina Taylor-Gjevre; Stan Van Uum; Hasnain M Khandwala
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

9.  Adrenomyeloneuropathy, a dynamic progressive disorder: brain magnetic resonance imaging of two cases.

Authors:  Yuan-Heng Mo; Ya-Fang Chen; Hon-Man Liu
Journal:  Neuroradiology       Date:  2004-03-04       Impact factor: 2.804

Review 10.  Diagnosis of inherited metabolic disorders affecting the nervous system.

Authors:  P D Swanson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.